Nanode Therapeutics, Inc. — Department of Health and Human Services SBIR Phase I: 4
Nanode Therapeutics, Inc. — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $441,150
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- Topic
- 4
- Solicitation
- PHS-2022-1
- NAICS
- —
- Place of performance
- RI
- Period
- —
Description
To develop a new, safe, and efficacious non-viral gene delivery system crossing the blood-brain barrier (BBB) for gene therapy of Alzheimer’s Disease (AD).